AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life.

We believe that OMIC technologies represent an important first step towards gaining biological insights into:

  • How drugs work, giving them added value, reducing attrition rates and advancing  through the clinic.
  • Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.


12/09/2019 | Tech Tour Contest Final 2019
AROMICS among the 175+ European innovative companies in the High-technology... More

11/26/2019 | Innovation and efficacy in drug discovery and development
An interactive forum and in-depth discussions with drug discovery and development... More


11/15/2019 | Working day on asbestos and its impact in human health
  On the 15th November 2019, the first scientific working session on... More

11/12/2019 | Aromics at 7th mRNA Health Conference in Berlin
Dr. Carme Plasencia, CEO of Aromics presented  on 11-12 November the progress... More